Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.80% Nasdaq Up 0.97%
Streaming
Ticker Tape: On

More On ALPMF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Astellas Pharma, Inc. (ALPMF)

-OTC Markets

56.70 0.00(0.00%) May 17, 8:10PM EDT

Add to Portfolio
Prev Close:56.70
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:38.40 - 57.49
Volume:100
Avg Vol (3m):227
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Astellas Pharma Inc. engages in the manufacture, marketing, and import/export of pharmaceutical products worldwide. The company primarily focuses on various therapeutic areas, urology, immunology and infectious diseases, oncology, neuroscience, an... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback